Details of the Drug Combinations

General Information of This Drug (ID: DM70IK5)

• Drug Name: Marinol (DM70IK5)
• Synonyms: Dronabinol; TETRAHYDROCANNABINOL; delta9-Tetrahydrocannabinol; delta9-THC; Deltanyne; Dronabinolum; delta-9-tetrahydrocannabinol; Abbott 40566; delta-9-THC; delta(9)-THC; 1972/8/3; delta1-THC; delta(sup 1)-Thc; delta(sup 9)-Thc; 1-trans-delta-9-Tetrahydrocannabinol; THC; Namisol; Dronabinolum [Latin]; 9-tetrahydrocannabinol; delta(9)-Tetrahydrocannabinol; delta(1)-Tetrahydrocannabinol; (-)-delta9-trans-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol; 1-trans-delta9-Tetrahydrocannabinol; delta(9)-Tetrahydrocannibinol; SP; Compassia; Ganja; Hashish; Marincap; MaxEPA; Omegaven; Promega; Relivar; Sonergx; Tetranabinex; Cannabis resin; Drona binol; QCD 84924; SP 104; Tetrahydrocannabinol delta9; CAT-310; DELTA1-THC; DELTA1-Tetrahydrocannabinol;DELTA9-THC; DRG-0138; Delta-THC; Delta1-THC; Delta1-Tetrahydrocannabinol; Delta9-THC; Delta9-Tetrahydrocannabinol; Delta9-Tetrahydrocannabinol solution; Dronabinol [USAN:INN]; Marinol (TN); Pro-Mega;QCD-84924; Trans-tetrahydrocannabinol; DELTA9-trans-Tetrahydrocannabinol; Delta(1)-THC; Delta(1)-Tetrahydrocannabinol; Delta(9)-THC; Delta(9)-Tetrahydrocannabinol; Delta(9)-Tetrahydrocannibinol; Delta(sup 1)-Tetrahydrocannabinol; Delta(sup 1)-Thc; Delta(sup 9)-Tetrahydrocannabinol; Delta(sup 9)-Thc; Delta(sup9)-THC; Delta-9-THC; Delta-9-tetrahydrocannabinol; Delta1-Tetrahydrocannabinol (VAN); Delta9-Tetrahydrocannabinol (VAN); Delta9-trans-Tetrahydrocannabinol; Dronabinol (USP/INN); Omega-3-Fatty acid; THC-delta-9; Trans-delta9-Tetrahydrocannabinol; Cannabinol, tetrahydro-(6CI); Fish oils, n-3 fatty acid-high; Fish oils, omega-3 fatty acid-high; L-delta(sup 1)-tetrahydrocannabinol; L-delta1-trans-Tetrahydrocannabinol; L-trans-delta9-Tetrahydrocannabinol; Trans-delta-9-Tetrahydrocannabinol; Cannabinol, Delta1-tetrahydro-(7CI); Fats and Glyceridic oils, fish, n-3 fatty acid-high; L-delta1-Tetrahydrocannabinol; Trans-DELTA9-Tetrahydrocannabinol; L-delta1-trans-Tetrahydrocannabinol;L-trans-delta9-Tetrahydrocannabinol; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; (-)-DELTA1-Tetrahydrocannabinol; (-)-DELTA9-THC; (-)-DELTA9-Tetrahydrocannabinol; (-)-DELTA9-trans-Tetrahydrocannabinol; (-)-delta(sup9)-trans-Tetrahydrocannabinol; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; (-)-delta1-Tetrahydrocannabinol; (-)-delta9-(trans)-Tetrahydrocannabinol; (-)-delta9-Tetrahydrocannabinol; (-)-trans-DELTA9-Tetrahydrocannabinol; (-)-trans-Delta1-Tetrahydrocannabinol; (-)-trans-Delta9-THC; (-)-trans-delta9-Tetrahydrocannabinol; (L)-delta1-Tetrahydrocannabinol; (l)-delta(sup 1)-Tetrahydrocannabinol; (l)-delta1-Tetrahydrocannabinol; 1-trans-delta(sup9)-tetrahydrocannabinol; 1-trans-D9-Tetrahydrocannabinol; 1-trans-delta(sup 9)-Tetrahydrocannabinol; 14C-DELTA1-Tetrahydrocannabinol; 6H-Dibenzo; 9-delta-Tetrahydrocannabinol; 9-ene-Tetrahydrocannabinol; Delta(9)-tetrahydrocannabinol

Indication

Anorexia nervosa cachexia; ICD 11: 6B80; Status: Approved [1]; Chemotherapy-induced nausea; ICD 11: MD90; Status: Phase 2/3 [2]

• Therapeutic Class: Analgesics
• Drug Type: Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

8 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Cannabidiol + Marinol	DCLSBDT	Cannabidiol	Dyslipidemias	[3]
Cannabidiol + Marinol	DCU4EJU	Cannabidiol	Cannabis Use Disorder	[4]
Cannabidiol + Marinol	DCYHVK0	Cannabidiol	Behavioral Pharmacology of Cannabinoids	[5]
Lofexidine + Marinol	DC45NE1	Lofexidine	Cannabis Dependence	[6]
Marinol + Acetaminophen	DCUQTIS	Acetaminophen	Behavioural Disturbances	[7]
Marinol + Caffeine	DCBWWFC	Caffeine	Behavioral Pharmacology of Cannabinoids	[5]
Marinol + Cyproheptadine	DC50T1X	Cyproheptadine	Pediatric Cancer	[8]
Dexamethasone + Marinol	DC1A7IL	Dexamethasone	Oncologic Complications	[9]

References

• [1] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018651.
• [2] Clinical pipeline report, company report or official report of INSYS Therapeutics.
• [3] ClinicalTrials.gov (NCT01217112) GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
• [4] ClinicalTrials.gov (NCT03398083) Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
• [5] ClinicalTrials.gov (NCT05478863) The Pharmacodynamics of Cannabinoid-Caffeine Combinations
• [6] ClinicalTrials.gov (NCT01020019) Combined Pharmacotherapy for Cannabis Dependency
• [7] ClinicalTrials.gov (NCT01608217) Delta-THC in Dementia
• [8] ClinicalTrials.gov (NCT06175273) Pediatric Oncology Nutrition Intervention Trial
• [9] ClinicalTrials.gov (NCT04155008) Nutrition and Pharmacological Algorithm for Oncology Patients Study